Descriptor English: | Triaziquone | ||||||
Descriptor Spanish: |
Triazicuona
| ||||||
Descriptor Portuguese: | Triaziquona | ||||||
Descriptor French: | Triaziquone | ||||||
Entry term(s): |
2,3,5-Tris(ethyleneimine)benzoquinone Trenimon |
||||||
Tree number(s): |
D03.383.097.217.900 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D014228 | ||||||
Scope note: | Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents, Alkylating |
||||||
Registry Number: | F3D5D9P25I | ||||||
CAS Type 1 Name: | 2,5-Cyclohexadiene-1,4-dione, 2,3,5-tris(1-aziridinyl)- | ||||||
Public MeSH Note: | 67 |
||||||
History Note: | 67(64) |
||||||
DeCS ID: | 14623 | ||||||
Unique ID: | D014228 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1967/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2016/06/01 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Triaziquone
- Preferred
Trenimon
- Narrower
Concept UI |
M0021909 |
Scope note | Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys. |
Preferred term | Triaziquone |
Entry term(s) |
2,3,5-Tris(ethyleneimine)benzoquinone |
Concept UI |
M0353135 |
Preferred term | Trenimon |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey